The discovery of a novel series of compounds with single-dose efficacy against juvenile and adult Schistosoma species.
Treatment and control of schistosomiasis depends on a single drug, praziquantel, but this is not ideal for several reasons including lack of potency against the juvenile stage of the parasite, dose size, and risk of resistance. We have optimised the properties of a series of compounds we discovered...
Guardado en:
Autores principales: | J Mark F Gardner, Nuha R Mansour, Andrew S Bell, Helena Helmby, Quentin Bickle |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7da0507681ce4b879d1f9d9c0948fc22 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screening.
por: Nuha R Mansour, et al.
Publicado: (2010) -
Ultraviolet disinfection of Schistosoma mansoni cercariae in water.
por: Lucinda Hazell, et al.
Publicado: (2021) -
Prevalence of Schistosoma mansoni infection among children in Ethiopia: a systematic review and meta-analysis
por: Habtye Bisetegn, et al.
Publicado: (2021) -
Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening.
por: Maha-Hamadien Abdulla, et al.
Publicado: (2009) -
Metabolomics reveal alterations in arachidonic acid metabolism in Schistosoma mekongi after exposure to praziquantel.
por: Peerut Chienwichai, et al.
Publicado: (2021)